MBL proudly announces a significant legal victory, securing the dismissal of tens of thousands of dollars in TPII bills for its insurance client. Associate Daniela Llenga, led by Partner Sulvia Alsaigh, successfully argued a Partial Summary Disposition Motion, demonstrating that the Nervomatrix treatment falls outside the scope of chiropractic care, is experimental and ineffective, and is therefore not a compensable allowable expense.

The Michigan Department of Licensing and Regulatory Affairs (LARA) places strict limits on the ordering of diagnostic tests by chiropractors, requiring them to be substantially equivalent to nationally recognized standards.

Expert review supported that TPII is neither approved by the Michigan Chiropractic Board nor meets nationally recognized standards.

The Court found that Plaintiff failed to provide objective, verifiable medical evidence proving the efficacy of TPII performed using the Nervomatrix device. As a result, the Court determined there was no genuine issue of material fact and dismissed all TPII bills for MBL’s insurance client.